What does Neptune Medical make?

Neptune Medical has no robot models recorded on the DEPLOY registry. Neptune Medical builds physical robots.

Who is the CEO of Neptune Medical?

Alex Tilson is the founder of Neptune Medical, per the DEPLOY registry.

Where is Neptune Medical headquartered?

Neptune Medical is headquartered in Menlo Park, CA.

Is Neptune Medical a top robotics company?

On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, Neptune Medical ranks in roughly the top 18% of companies tracked by the registry.

Is Neptune Medical safe?

Neptune Medical has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.

Neptune Medical: robotics company

Overview

Menlo Park, CA-based GI robotics developer. Founder/CEO Alex Tilson. $97M Series D (August 2024). Investors: Sonder Capital, Olympus Corporation. Product: Pathfinder sleeve (wraps around endoscope, stiffens to prevent loops). Subsidiaries: Jupiter Endovascular (spun out with $21M, Endoportal Control for pulmonary embolism, led by Carl St. Bernard), Triton Medical Robotics (flexible endoluminal surgical device). Focus: GI robotics.

Verified record

Verified deployments: None on file
Active incidents: None on file

Key facts

Series D

$97M (August 2024, Sonder Capital + Olympus)

Founder/CEO

Alex Tilson

Product

Pathfinder — endoscope stiffening sleeve for GI procedures

Subsidiaries

Jupiter Endovascular (spun out, $21M, pulmonary embolism), Triton Medical Robotics

HQ

Menlo Park, CA

Data & sources

Web sources

2

2 sources backing this record.View all →

Neptune Medical on the deployment map

Where Neptune Medical's robots are verified operating. Explore the deployment map by place and type.

The global deployment map →

Current leadership (2)

Alex Tilson Founder & CEOreported, not verified
Fred Moll Chairman of the Boardsecondary-verified

Safety record

No incidents on record for Neptune Medical.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Recent coverage

Neptune Medical in third-party press

Inside Biotech: Healthcare robotics enters its next phase as GI systems gain momentum - Proactive financial news

May 8, 2026

Neptune Medical’s GI robot succeeds in colonoscopy study - MedTech Dive

May 6, 2026

50-Patient First-in-Human Study of Triton Robotic Endoscopy System From Neptune Medical Demonstrates No Adverse Events and 100% Cecal Intubation in Colonoscopy - Business Wire

May 5, 2026

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Record createdJul 22, 2026
Added to the verified registry

Full change history →

Sources (2)

Common questions

What is Neptune Medical?: Menlo Park, CA-based GI robotics developer. Founder/CEO Alex Tilson. $97M Series D (August 2024). Investors: Sonder Capital, Olympus Corporation. Product: Pathfinder sleeve (wraps around endoscope, stiffens to prevent loops). Subsidiaries: Jupiter Endovascular (spun out with $21M, Endoportal Control for pulmonary embolism, led by Carl St. Bernard), Triton Medical Robotics (flexible endoluminal surgical device). Focus: GI robotics.
What does Neptune Medical make?: Neptune Medical has no robot models recorded on the DEPLOY registry. Neptune Medical builds physical robots.
Who is the CEO of Neptune Medical?: Alex Tilson is the founder of Neptune Medical, per the DEPLOY registry.
Where is Neptune Medical headquartered?: Neptune Medical is headquartered in Menlo Park, CA.
Is Neptune Medical a top robotics company?: On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, Neptune Medical ranks in roughly the top 18% of companies tracked by the registry.
Is Neptune Medical safe?: Neptune Medical has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.

Methodology: Verified · 2 sources (no primary) · last reviewed 2026-07-22

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-07-22

Sources by quality tier

2: unclassified; Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

<a…

↗

Machine-readable surfaces

Markdown mirror: /companies/neptune-medical.md
RSS feed: /companies/neptune-medical/feed.xml
JSON-LD: embedded in this page’s head
REST API: /v1/companies/79af1772-cc80-4ac7-abe1-60a8ea799ed8
Revision history: /companies/neptune-medical/history
Data documentation: /data
Query this programmatically: Deploy MCP

Reality vs attention

Not enough verified signal yet to place Neptune Medical against peers. Reality and attention percentiles publish once the underlying record clears its data floor.

6-month trend

Peer rankingTop 18% of category

vs funding peers-13.9 ptsbelow funding-adj. expected

Analysis

Limited public visibility and press coverage relative to peers.

Dimension breakdown

Verified signal

Insufficient data

Insufficient data

Insufficient data

Insufficient data

Insufficient data

Attention (reach, not merit)

Market Presence →

22.522.5HIGH

DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.

DEPLOY Indices — verified vs claimed

Claim Integrity Fleet Reality Operator Repeat All indices

Last computed: Jul 25, 2026

Methodology Intelligence layer